Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2017-08-03 2017-08-03
Drug Identification Number 02320150 02320150
Brand name PACLITAXEL INJECTION USP PACLITAXEL INJECTION USP
Common or Proper name PACLITAXEL PACLITAXEL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients PACLITAXEL PACLITAXEL
Strength(s) 6MG 6MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50ML VIAL 50ML VIAL
ATC code L01CD L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-07-19 2017-07-19
Actual start date
Estimated end date 2017-07-31 2017-07-31
Actual end date 2017-07-28 2017-07-28
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments